# Yohei Doi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yohei-doi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,267 |
| Field | Antibiotic Resistance in Bacteria |
| h-index | 94 |
| i10-index | 336 |
| Last Known Institution | Fujita Health University |
| OpenAlex ID | https://openalex.org/A5006534529 |
| ORCID iD | 0000-0002-9620-2525 |
| Works | 610 |

## Researcher papers

Showing 12 of 16.

- [Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study](https://scholariq.org/papers/emergence-of-plasmid-mediated-colistin-resistance-mechanism-mcr-1-in-animals-and/)
- [The global epidemiology of carbapenemase-producing Enterobacteriaceae](https://scholariq.org/papers/the-global-epidemiology-of-carbapenemase-producing-enterobacteriaceae/)
- [Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-cefiderocol-or-best-available-therapy-for-the-treatment/)
- [Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)](https://scholariq.org/papers/colistin-and-its-role-in-the-era-of-antibiotic-resistance-an-extended-review/)
- [Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections](https://scholariq.org/papers/treatment-options-for-carbapenem-resistant-gram-negative-bacterial-infections/)
- [Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae](https://scholariq.org/papers/colistin-versus-ceftazidime-avibactam-in-the-treatment-of-infections-due-to/)
- [Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens](https://scholariq.org/papers/treatment-outcome-of-bacteremia-due-to-kpc-producing-klebsiella-pneumoniae/)
- [16S Ribosomal RNA Methylation: Emerging Resistance Mechanism against Aminoglycosides](https://scholariq.org/papers/16s-ribosomal-rna-methylation-emerging-resistance-mechanism-against/)
- [Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study](https://scholariq.org/papers/effect-of-appropriate-combination-therapy-on-mortality-of-patients-with/)
- [Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia](https://scholariq.org/papers/ceftazidime-avibactam-is-superior-to-other-treatment-regimens-against-carbapenem/)
- [Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance](https://scholariq.org/papers/colistin-resistant-acinetobacter-baumannii-beyond-carbapenem-resistance/)
- [Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study](https://scholariq.org/papers/prevalence-risk-factors-outcomes-and-molecular-epidemiology-of-mcr-1-positive/)

## Researcher topics

- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)
- [Bacterial Identification and Susceptibility Testing](https://scholariq.org/topics/bacterial-identification-and-susceptibility-testing/)
- [Vibrio bacteria research studies](https://scholariq.org/topics/vibrio-bacteria-research-studies/)

## Researcher university

- [Fujita Health University](https://scholariq.org/institutions/fujita-health-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.